NicOx and TOPIGEN Pharmaceuticals terminate collaboration following the acquisition of TOPIGEN by Pharmaxis
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants
Nicox: 2023 Ordinary Shareholder Meeting
NicOx S.A. - HealthCap
Nicox Stock Forecast: down to 0.000001 USD? - NICXF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Nicox Reports 2021 Financial Results and First Quarter 2022 Highlights
NICOX SA EUR ORD NEW (NICXF) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow (OTCMKTS:NICXF) | Seeking Alpha
Portal Hypertension in the 21st Century: The proceedings of a symposium sponsored by Axcan Pharma Inc. and NicOx S.A., held in Montrél, Canada, April 2–4, 2004: Groszmann, R.J., Bosch, J.: 9789401037747: Amazon.com: Books
Nicox - Revisiting commercial assumptions
Nicox Company Profile: Stock Performance & Earnings | PitchBook
Nicox resubmits AC-170 NDA after API supplier resolves GMP issues
Catalog produse Nicox Pharma
0,561/0,565) Nicox S.A.
NicOx S.A. decides against complete Altacor equity - Hospital Pharmacy EuropeHospital Pharmacy Europe
Nicox Stock Forecast: down to 0.000001 USD? - NICXF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
0,561/0,565) Nicox S.A.
Nicox Reports Fourth Quarter 2021 and Full-Year Revenue Slump
NICOX SA : Cours Action Bourse | ALCOX | FR0013018124 | Zonebourse
NicOx successfully completes its right issue, raising €100 million following a two-step capital increase
Nicox and Ocumension broaden two agreements in South East Asia